-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $350 Price Target

Benzinga·07/06/2026 12:56:13
Listen to the news
Cantor Fitzgerald analyst Carter Gould reiterates Amgen (NASDAQ:AMGN) with a Neutral and maintains $350 price target.